Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Hemo Organic Ltd (HEMORGANIC) Share Price & Fundamentals

Company Overview

Founded Year

1992

Listed Year

-

Headquarter

Ahmedabad, Gujarat, India

MD/CEO

-

Website

http://www.hemoorganic.co

Company Facts

What we do

Hemo Organic Limited manufactures chemical intermediates for pharmaceuticals and leather industries, and trades in rice and textiles.

Founded in

1,992

Market share

Emerging player in niche chemical intermediates with growing presence in trading sectors.

Problem solved

Provides essential chemical intermediates critical to pharmaceutical production and leather processing, addressing industry demand gaps.

Top clients or who we serve

Primarily serves pharmaceutical, leather, textile industries with B2B focus.

Key management

-

Our journey and innovations

Incorporated in 1992, shifted from chemical manufacturing to trading and new chemical project commissioning since 2013.

Where we operate

Operates mainly in India, with manufacturing near Khambhat, Gujarat.

Top products or what we offer

2.6 Di Chloro Aniline and Para Chloro Meta Cresol chemical intermediates; rice and textile trading.

Top brands

-

Raw materials needed

Chemical precursors for 2.6 Di Chloro Aniline and Para Chloro Meta Cresol manufacturing.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue mainly cyclical, tied to industrial chemical demand cycles.

Our industry position

Small but growing presence in niche chemical intermediates segment, expanding after previous pollution-related halt.

Financial highlights

FY 2024-25 revenue Rs. 2.41 Cr, net profit Rs. 0.16 Cr, turnaround from prior year loss.

Geographical revenue split

Revenue predominantly domestic Indian markets.

Order book

-

Whats driving growth

New chemical production capacity and expanding trading activities driving growth.

Our future plans

Capacity expansion in chemical manufacturing and right issue funding planned.

Our green promise

-

Our people and values

-

Key challenges ahead

Managing regulatory compliance, environmental controls, and scaling production sustainably.

Interesting facts

Successfully repositioned after pollution issues, now diversifying into pharmaceuticals and leather chemical intermediates.

Risks and strategy

Mitigates environmental and market risks through compliance and diversification in chemical products.

Market Footprint

Top Clients

Top Clients

Primarily serves pharmaceutical, leather, textile industries with B2B focus.

Top Products

Top Products

2.6 Di Chloro Aniline and Para Chloro Meta Cresol chemical intermediates; rice and textile trading.

Price Movement & Share Holding

Today's High/Low

21.8322.97

52 Week High/Low

8.3124.42
Past Returns

1 week

-4.88%

1 month

4.85%

3 month

-10.52%

1 year

159.81%

3 year

265.38%

5 year

165.17%

Share Holding

Promoters

2.5%

FII

0%

DII

0%

Retail

43.05%

Others

54.45%

Company Overview

Founded Year

1992

Listed Year

-

Headquarter

Ahmedabad, Gujarat, India

MD/CEO

-

Website

http://www.hemoorganic.co

Price Movement & Share Holding

Today's High/Low

21.8322.97

52 Week High/Low

8.3124.42

Past Returns

1 week

-4.88%

1 month

4.85%

3 month

-10.52%

1 year

159.81%

3 year

265.38%

5 year

165.17%

Share Holding

Promoters

2.5%

FII

0%

DII

0%

Retail

43.05%

Others

54.45%

Company Facts

What we do

Hemo Organic Limited manufactures chemical intermediates for pharmaceuticals and leather industries, and trades in rice and textiles.

Founded in

1992

Market share

Emerging player in niche chemical intermediates with growing presence in trading sectors.

Problem solved

Provides essential chemical intermediates critical to pharmaceutical production and leather processing, addressing industry demand gaps.

Top clients or who we serve

Primarily serves pharmaceutical, leather, textile industries with B2B focus.

Our journey and innovations

Incorporated in 1992, shifted from chemical manufacturing to trading and new chemical project commissioning since 2013.

Where we operate

Operates mainly in India, with manufacturing near Khambhat, Gujarat.

Top products or what we offer

2.6 Di Chloro Aniline and Para Chloro Meta Cresol chemical intermediates; rice and textile trading.

Raw materials needed

Chemical precursors for 2.6 Di Chloro Aniline and Para Chloro Meta Cresol manufacturing.

Recurring vs cyclical contribution

Revenue mainly cyclical, tied to industrial chemical demand cycles.

Our industry position

Small but growing presence in niche chemical intermediates segment, expanding after previous pollution-related halt.

Financial highlights

FY 2024-25 revenue Rs. 2.41 Cr, net profit Rs. 0.16 Cr, turnaround from prior year loss.

Geographical revenue split

Revenue predominantly domestic Indian markets.

Whats driving growth

New chemical production capacity and expanding trading activities driving growth.

Our future plans

Capacity expansion in chemical manufacturing and right issue funding planned.

Key challenges ahead

Managing regulatory compliance, environmental controls, and scaling production sustainably.

Interesting facts

Successfully repositioned after pollution issues, now diversifying into pharmaceuticals and leather chemical intermediates.

Risks and strategy

Mitigates environmental and market risks through compliance and diversification in chemical products.

Market Footprint

Top Clients

Top Clients

Primarily serves pharmaceutical, leather, textile industries with B2B focus.

Top Products

Top Products

2.6 Di Chloro Aniline and Para Chloro Meta Cresol chemical intermediates; rice and textile trading.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions